Last edition
News about
Efforts By DoP To Make India The Diagnostic Capital Of The World
The National Medical Device Policy was presented with an outlook paper by the Department of Pharmaceuticals (DoP), stating a conscript for the stakeholder?s evaluation to position India as the real 'Diagnostic Capital of the World'
First reference lab in Kolkata launched by Lupin
The new Reference Laboratory at Kolkata has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology and routine biochemistry
Thyrocare set to expand regional processing lab in Jaipur & Vizag
Thyrocare, one of India's leading healthcare service providers in the diagnostic segment, is all set for expansion once again. With 4 regional processing labs operational in the current quarter, in Nagpur, Ranchi, Raipur and Ahmedabad, Thyrocare is all set to launch 2 regional processing labs in Jaipur and Visakhapatnam (Vizag) in March 2022
Wipro and Pandorum partner to accelerate regenerative medicine with AI
Wipro and Pandorum Technologies today announced a long-term partnership. Together, the companies will focus on development of technologies that shorten time-to-market and maximise patient outcome during R&D and clinical trials of regenerative medicine. The partnership combines the Artificial Intelligence (AI) capabilities of Wipro Holmes with Pandorum's
WHO GDP certification won by Venus Remedies for quality services across entire supply chain
SGS awarded the WHO GDP certification to Venus Remedies following an elaborate audit. Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards, added the statement
Authorities should play a more proactive role in protecting Indian consumers from the clutches of the global nexus of pharma and drug mafias. The onus lies on the government to tighten the noose of such global nexus and nab wolves in sheep's clothing
Sebi approves for Rs 600 crores IPO to Hexagon Nutrition
It said that the company had filed its draft prospectus in December 2021. The IPO consists of a fresh issue of shares worth Rs 100 crores and an Offer For Sale (OFS) of up to 30,113,918 equity shares, as per the company's Draft Red Herring Prospectus (DRHP)
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Intas Pharmaceuticals immunising agent immunoglobulin combination at 15 per cent higher than the existing human normal immunoglobulin solution for infusion 5%, since it is an incremental innovation having advantage without any increased side effect
US FDA approval: Lupin can now market its generic drugs
In its recent statement Lupin has said that it received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market
Collaboration between ICMR and Pharma companies to develop Dengue vaccine
With the rise in dengue cases across the country, the Indian Council of Medical Research (ICMR) has embarked on an initiative aiming to facilitate development of dengue vaccine. Vaccine manufacturer and pharma companies who have developed or have license of tetravalent dengue vaccine candidate and have successfully completed its phase I and phase II
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy